In past years, laboratory diagnosis and surveillance of urinarybladdercancer have improved significantly.
2
In this study, we aimed to investigate the physiological role of GPR137 in urinarybladdercancer.
3
Lung cancer is third, followed by colon cancer, women with cancer of the uterus, and urinarybladdercancer.
4
Knowing the HER-2 status would be helpful in formulating a rational treatment strategy for patients with urinarybladdercancer.
5
Increases in incidence of non-Hodgkin's lymphoma and of cervical, esophageal, and urinarybladdercancer have been observed for workers exposed to Perc.
1
Conclusions: Fibulin-5 is down-regulated in urothelial carcinomaofbladder and acts as a tumor suppressor gene by inhibiting proliferation and invasion of bladder cancer cells.
2
Purpose: The expression of fibulin-5 was investigated in urothelial carcinomasofbladder and in normal bladder samples.
1
Advanced urothelial carcinomaofthebladder is associated with a high metastatic potential.
2
Transitional cell carcinomaofthebladder is a chemo-sensitive neoplasm.
3
The patient was a 64-year-old woman being followed up for transitional cell carcinomaofthebladder.
4
A conservative primary approach seems justifiable in the management of double carcinomaofthebladder and prostate.
5
Background: Recurrence of transitional cell carcinomaofthebladder cannot be predicted accurately by traditional criteria alone.
1
It was around that time, too, that Daldry's father died of cancerofthebladder.
2
In this article, we review available evidence on the treatment of patients with nonurothelial cancerofthebladder.
3
Discovery of blood in the urine took him to Manhattan's Memorial Hospital with suspected cancerofthebladder.
4
Kray, 66, is terminally ill with cancerofthebladder and has a life expectancy of only a few weeks.
5
This reduction was especially marked for cancer in the respiratory system, cancer of the prostate and cancerofthebladder.
1
Purpose: The standard treatment for patients with muscle-invasive carcinomaoftheurinarybladder is radical cystectomy.
2
We treated in total 795 patients with primary transitional cell carcinomaoftheurinarybladder between April, 1964 and December, 1988.
3
Conclusion: Over-expression of HER-2 was frequent in carcinomasoftheurinarybladder.
4
Two hundred eighty-five primary human carcinomasoftheurinarybladder were examined for allelic loss on chromosome 14q.
5
The relationship between interphase cytogenetics and tumor grade, stage, and proliferative activity was investigated in 27 transitional cell carcinomasoftheurinarybladder.
1
However, the mechanisms responsible for angiogenesis in urinarybladdercarcinoma patients are not well defined.
2
Computed tomography showed diffuse, circumferential, irregular, and lobulated thickening of the bladder wall suggestive of urinarybladdercarcinoma.
3
The AR is also involved in the development and progression of urinarybladdercarcinoma, which is the most common type of carcinoma.
4
It may be suggested that the urinarybladdercarcinoma induced by CPM is related not only total dose of CPM but also the other factors.
5
A case of urinarybladdercarcinoma in a patient with malignant lymphoma (ML) involving the thyroid gland, gastrointestinal tract and the gallbladder is reported.
Uso de bladder carcinoma en inglés
1
Studies on HER-2 expression in bladdercarcinoma have shown heterogeneous results.
2
Brachytherapy has a key role to play in the treatment of bladdercarcinoma.
3
Pathologic examination showed similar histologic and immunohistochemical characteristics as the primary bladdercarcinoma.
4
Purpose: We report the presentation of brain metastases from bladdercarcinoma.
5
Results: Brain metastases from bladdercarcinoma were commonly accompanied by uncontrolled systemic metastases.
6
Conclusions: Overall survival after brain metastasis development in patients with bladdercarcinoma was poor.
7
However, the mechanisms responsible for angiogenesis in urinary bladdercarcinoma patients are not well defined.
8
The in vitro proliferation of both bladdercarcinoma cell lines was also inhibited by TNP-470.
9
However, no ultrasonic enhancement of doxorubicin growth inhibition in these human bladdercarcinoma cells was observed.
10
The data indicated that ARCON could achieve a therapeutic gain in patients with advanced bladdercarcinoma.
11
Photochemotherapy of bladdercarcinoma in situ still constitutes a complex treatment protocol reserved for specialized centres.
12
Background: The clinical behavior of the tumor in patients with locally advanced bladdercarcinoma is unpredictable.
13
Conclusion: This study indicates thatΔNp63 gene down-expression can reduce the invasion of bladdercarcinoma cells in vitro.
14
Computed tomography showed diffuse, circumferential, irregular, and lobulated thickening of the bladder wall suggestive of urinary bladdercarcinoma.
15
These data identify distinct regions of loss on chromosome 4 potentially involved in the late progression of bladdercarcinoma.
16
Conclusions: These findings indicate that TD mutations in the FGFR3 gene do not cause disease progression of bladdercarcinoma.